Harvard Bioscience (HBIO) Profit Margin (2010 - 2026)
Harvard Bioscience (HBIO) profit margin from Jun 30, 2010 to Mar 31, 2026. The current Harvard Bioscience (HBIO) profit margin is -16.47%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Harvard Bioscience (HBIO)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | -65.51% | +397.36% |
| 2024 | -13.17% | +333.59% |
| 2023 | -3.04% | -63.83% |
| 2022 | -8.40% | +3343.80% |
| 2021 | -0.24% | -96.81% |
| 2020 | -7.65% | N/A |
| 2020 | -7.65% | -530.73% |
| 2019 | 1.78% | -143.99% |
| 2019 | -4.04% | +66.96% |
| 2018 | -2.42% | +166.33% |
| 2018 | -0.91% | -80.40% |
| 2018 | -4.63% | -69.47% |
| 2018 | -15.17% | +1265.65% |
| 2017 | -1.11% | -50.48% |
| 2017 | -2.24% | +11.94% |
| 2017 | -2.00% | -66.12% |
| 2017 | -5.91% | +43.44% |
| 2016 | -4.12% | -37.11% |
| 2016 | -6.56% | +141.42% |
| 2016 | -2.72% | +14.42% |
| 2016 | -2.37% | -86.45% |
| 2015 | -17.52% | +430.42% |
| 2015 | -3.30% | -371.83% |
| 2015 | 1.22% | -122.36% |
| 2015 | -5.43% | -350.23% |
| 2014 | 2.17% | -12.26% |
| 2014 | 2.48% | -34.57% |
| 2014 | 3.78% | +36.04% |
| 2014 | 2.78% | -259.82% |
| 2013 | -1.74% | -55.36% |
| 2013 | -3.90% | +435.28% |
| 2013 | -0.73% | -290.00% |
| 2013 | 0.38% | -82.02% |
| 2012 | 2.13% | -528.01% |
| 2012 | -0.50% | -118.44% |
| 2012 | 2.70% | +44.37% |
| 2012 | 1.87% | -46.53% |
| 2011 | 3.50% | +2977.59% |
| 2011 | 0.11% | -97.75% |
| 2011 | 5.05% | -20.95% |
| 2011 | 6.39% | -63.68% |
| 2010 | 17.58% | +108.57% |
| 2009 | 8.43% | N/A |
Comparison Harvard Bioscience (HBIO) profit margin with competitors
Harvard Bioscience (HBIO) profit margin is -16.47%.